By Robert Pieper (ERNI Germany)
The medical technology industry is entering a new phase. Artificial intelligence, connected devices and digital health platforms have dominated industry conversations for years. This year’s MedConf in Munich, which took place in May, revealed a clear shift in focus: MedTech companies are no longer asking what is possible. They are asking how to implement innovation safely, efficiently and compliantly. Across presentations, workshops and expert discussions, several key trends emerged that are likely to shape the future of MedTech development over the coming years.
AI is moving from experimentation to real clinical value
Artificial intelligence was one of the dominant topics throughout the conference. However, the conversation has matured significantly. Instead of discussing AI as a future opportunity, speakers concentrated on practical deployment challenges, validation approaches and regulatory expectations. The focus is shifting towards trustworthy AI systems that can support clinical decision-making, automate workflows and improve patient outcomes while remaining explainable and auditable.
For MedTech companies, the challenge is far more than developing AI models. It is integrating them into regulated medical devices and maintaining compliance throughout the product lifecycle.
Cybersecurity has become a patient safety issue
Cybersecurity – instead of being treated as an isolated IT concern – is increasingly viewed as a core patient safety requirement. As medical devices become more connected and software-driven, the attack surface continues to grow. Discussions at MedConf highlighted the need for security-by-design approaches, continuous monitoring and secure update mechanisms.
Particularly for AI-enabled devices, manufacturers face additional challenges related to data integrity, model security and protection against cyber threats that could compromise device performance. In many organisations, cybersecurity is becoming an integral part of both product development and risk management processes.
Connected devices and interoperability are finally becoming business priorities
The era of standalone medical devices is coming to an end. Healthcare providers expect devices, software platforms and hospital systems to exchange information seamlessly. As a result, interoperability has become a strategic business requirement rather than a technical afterthought.
Manufacturers are investing more heavily in device connectivity, data integration and standardised communication interfaces to support connected care ecosystems. The ability to integrate into broader healthcare infrastructures may soon become as important as the device’s core functionality itself.
Regulatory complexity continues to drive innovation
Regulations remain one of the strongest forces shaping MedTech development. The ongoing impact of MDR, evolving cybersecurity requirements and upcoming AI regulations are pushing organisations to rethink how they develop products and manage documentation.
One recurring theme at MedConf was the growing need to embed compliance into development processes from the beginning rather than treating it as a final approval step. Companies that successfully combine innovation with regulatory readiness are increasingly gaining a competitive advantage.
Requirements engineering is becoming a strategic discipline
As medical devices become more software-intensive and multidisciplinary, requirements engineering is gaining renewed attention. Several conference sessions focused on traceability, systems thinking and model-based approaches that help teams manage complexity across development, quality assurance and regulatory activities.
The traditional view of requirements as static documents is gradually being replaced by a more integrated approach that connects requirements, risks, testing and validation throughout the entire product lifecycle. For organisations developing complex systems, this shift is becoming essential for maintaining speed without sacrificing compliance.
Validation is going digital
Another notable trend was the move away from document-heavy validation processes towards more digital and automated approaches. With increasing release frequencies, cloud-based architectures and connected systems, traditional validation methods are struggling to keep pace.
Forward-looking organisations are exploring automated testing, digital validation workflows and continuous verification strategies that align better with modern software development practices. This transformation is helping teams reduce compliance overhead while improving product quality.
Looking ahead
The strongest message from MedConf 2026 was that MedTech innovation is becoming more and more software-defined. Artificial intelligence, connected ecosystems, cybersecurity and regulatory excellence are not separate topics. They are converging into a single ecosystem made up of innovative medical technologies that can be trusted, validated and safely deployed at scale.
